Silver Book reference

Pegaptanib for Neovascular Age-Related Macular Degeneration

1 Matching Fact

Search matching Facts:
No results to display
    • Macugen to treat wet age-related macular degeneration (AMD)
      A new FDA-approved ophthalmic drug that treats wet age-related macular degeneration (AMD)– pegaptanib sodium (Macugen)– reduced vision loss in 70% of clinical trial patients.